SCHEMBL8288362

SCHEMBL8288362

CCOC(=O)c1c(-c2ccc(C(F)(F)F)cc2)c(C#N)cn1C

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.45
MAPT P10636 4/20 0.42
MEN1 O00255 1/20 0.42
HSP90AA1 P07900 1/20 0.42
CRHBP P24387 1/20 0.42
KMT2A Q03164 1/20 0.42
CRHR2 Q13324 1/20 0.42
HTT P42858 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
ATM Q13315 1/20 0.39
NPSR1 Q6W5P4 2/20 0.39
MLYCD O95822 2/20 0.39
ALDH1A1 P00352 1/20 0.39
ADORA3 P0DMS8 1/20 0.39
FOS P01100 1/20 0.38
JUN P05412 1/20 0.38
NFKB1 P19838 1/20 0.38
NFKB2 Q00653 1/20 0.38
RELA Q04206 1/20 0.38
TRPM2 O94759 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8287323 0.86 GRIA2 (0.46) KDM4EMAPTMEN1KMT2ASMN1; SMN2
SCHEMBL4377035 0.86 FNTA (0.47) KDM4EMAPTMEN1KMT2ASMN1; SMN2
SCHEMBL8289327 0.85 AR (0.43) KDM4EALDH1A1
SCHEMBL4374450 0.85 HTT (0.48) KDM4EMAPTMEN1KMT2AHTT
SCHEMBL8288366 0.85 KDM4E (0.53) KDM4EMAPTMEN1KMT2AHTT
SCHEMBL8289281 0.84 KDM4E (0.49) KDM4EMAPTMEN1KMT2AHTT
SCHEMBL13611594 0.83 KDM4E (0.42) KDM4EMAPTMEN1KMT2ANPSR1
SCHEMBL4558565 0.82 MEN1 (0.48) KDM4EMAPTMEN1KMT2AHTT
SCHEMBL8289780 0.82 GRIA2 (0.52) KDM4EMAPTMEN1KMT2AHTT
SCHEMBL8289331 0.81 GRIA2 (0.51) KDM4EMAPTMEN1KMT2AHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7625932-B2 Pyrrole and pyrazole derivatives as potentiators of glutamate receptors ELI LILLY AND COMPANY (US) 2009-12-01 US disclosed
EP-1670757-B1 PYRROLE AND PYRAZOLE DERIVATIVES AS POTENTIATORS OF GLUTAMATE RECEPTORS LILLY CO ELI (US) 2009-05-06 EP disclosed
US-20070066573-A1 Pyrrole and pyrazole derivatives as potentiators of glutamate receptors ELI LILLY AND COMPANY 2007-03-22 US disclosed
WO-2005040110-A1 PYRROLE AND PYRAZOLE DERIVATIVES AS POTENTIATORS OF GLUTAMATE RECEPTORS ELI LILLY AND COMPANY (US) 2005-05-06 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070066573-A1 Pyrrole and pyrazole derivatives as potentiators of glutamate receptors GRIN1, GRIN3A, GRIK5 KDM4E 2620/4885MAPT 558/4885MEN1 4720/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.